Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023;21:1067–96.
2. Ötleş E, Denton BT, Qu B, Murali A, Merdan S, Auffenberg GB, et al. Development and validation of models to predict pathological outcomes of radical prostatectomy in regional and national cohorts. J Urol. 2022;207:358–66.
3. Brady Urological Institute. Partin Tables Prostate Cancer Risk Assessment Tool. 2021. Available from: https://www.hopkinsmedicine.org/brady-urology-institute/conditions_and_treatments/prostate_cancer/risk_assessment_tools/partin-tables.html.
4. Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, et al. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Eur Urol. 2012;61:480–7.
5. Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol. 2003;170:1798–803.